Page 127 - Azerbaijan State University of Economics
P. 127

THE JOURNAL OF ECONOMIC SCIENCES: THEORY AND  PRACTICE, V.71,  # 1, 2014,  pp. 127-139



                 HEALTH ECONOMIC VALUE GENERATION IN THE AZERBAIJAN REPUBLIC:
                     SIMULATEDRESULTS FOR A INTEGRATED TELECARDIOLOGY CARE
                                                      PROGRAM

                                                    Christian Elsner
                     CEO at University ClinicUniversitätsklinikum Schleswig-Holstein,Campus Lübeck,
                                  RatzeburgerAllee 160 (MFC 5, 3. OG) in 23538 Lübeck,
                                              Email [email protected]

                                                      DennisHäckl
                             WIG Wissenschaftliches Institut, Nikolaistraße 6-10, 04109 Leipzig

                       Received January 6 2014; accepted 15 Mayl 2014; published online 15 July 2014

                                                        Abstract

                     Economic feasibility studies  for  Health-Technology  Assessment (HTA) become more  and

               more important over time. While the data situation is quite good in industrialized countries, it is quite

               hard to predict health  economic values  in countries with  a developing healthcare  system.  In the


               Azerbaijan  Republic (AR) thereis a  problematicdatasituation  on theexactepidemiology oft he

               Congestive Heart Failure (CHF)  and  a  not  tooprecisedatasituation on healthcarecost.


               Thiasworktriestointerpolatethe worth of a disease management program for cardiac diseases in the

               AR system and understands itself as a “best guess” and methodology to recalculate the effects with a

               better and growing data situation.Additionally a risk sharing approach implementing better incentive


               mechanisms was discussed.The entities taken into account by the simulation model were the impacts

               on heart attack, stroke and heart failure. The Simulation took place atthe simulated AR population

               with specific morbidity criteria.According to the simulation a per patient gross saving of 323,53 US$


               per year was reached over all entities. The real cost saving without a QALY saving effect would be at

               a 111,33 US$ per year. Taking also the new technology implementation cost into account, a positive

               return would only be generated over  the additional QALY effect. Overall the technology could


               produce a QALY effect of 8889 QALYs per year in the AR.




                                                           127
   122   123   124   125   126   127   128   129   130   131   132